A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...
Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...
Take a look back into biotech in 2025 as the year is closing - from GLP-1s to radiopharmaceuticals and neuroplastogens.
BIO-Europe Startup Spotlight returns to Lisbon in March 2026, showcasing Europe’s top early-stage biotech pitches to industry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results